Connect Sign In
ARUP announced an investment in Techcyte Inc. as part of the company’s new $21 million funding round. This will enable Techcyte to expand the development team for its digital diagnostics platform.
A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 neutralizing antibodies, according to an analysis recently published by experts at ARUP Laboratories.
Deep Bio announced a research collaboration agreement with ARUP Laboratories. Deep Bio’s AI-based prostate cancer diagnosis software will be used for the joint research.
GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its workflows.
ARUP’s Adam Barker, PhD, will be the featured presenter during the Dark Intelligence Group’s COVID-19 STAT Intelligence Briefing at 10 a.m. MDT on Tuesday, April 27.
The CDC has cited research in which the University of Utah’s HERO Project and ARUP Laboratories played a key role. The research is integral to new physical distancing guidelines.
Kimberley Evason, MD, PhD, and Gregory Ducker, PhD, are two of only 12 scientists nationwide to receive the 2020 Damon-Runyon-Rachleff Innovation Award for their liver cancer research.
ARUP Laboratories and Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, have developed the world’s first AI-augmented ova and parasite detection tool.
In a recently published study, Allie Grossmann, MD, PhD, details one factor behind how and why melanoma metastasizes so quickly while identifying better ways to treat this lethal skin cancer.
Recently, three scientists at ARUP published a study that shows how symptoms of CM-AVM can be distinguished from a similar disorder, hereditary hemorrhagic telangiectasia (HHT).
The plague provides a subject for Mark Fisher’s current National Institutes of Health (NIH) grant-funded project.
ARUP’s Tech Fair showcases the inventions and innovations of individuals in Automation Engineering, Clinical Systems, Information Technology, and other in-house “builders.”
